High-dimensional propensity score adjustment in studies of treatment effects using health care claims data.

Cited by (1,000)

Items 201–300 of 1,000

1. Dynamic network data envelopment analysis with a sequential structure and behavioural-causal analysis: Application to the Chinese banking industry
   Hirofumi Fukuyama, Efthymios G. Tsionas, Yong Tan · 2022 · European Journal of Operational Research
2. Real World Data in Adaptive Biomedical Innovation: A Framework for Generating Evidence Fit for Decision‐Making
   Sebastian Schneeweiß, H‐G Eichler, Anna García‐Altés, Christopher Chinn, A‐V Eggimann, S Garner, Wim Goettsch, Robyn R. Lim, Wiebke Löbker, D Martin et al. · 2016 · Clinical Pharmacology & Therapeutics
3. Can We Train Machine Learning Methods to Outperform the High-dimensional Propensity Score Algorithm?
   Mohammad Ehsanul Karim, Menglan Pang, Robert William Platt · 2017 · Epidemiology
4. A Method to Combine Signals from Spontaneous Reporting Systems and Observational Healthcare Data to Detect Adverse Drug Reactions
   Ying Li, Patrick B. Ryan, Ying Wei, Carol Friedman · 2015 · Drug Safety
5. Association of early post-discharge follow-up by a primary care physician and 30-day rehospitalization among older adults.
   Field, Terry S., Ogarek, Jessica, Garber, Lawrence, Reed, George, Gurwitz, Jerry H. · 2015 · Journal of General Internal Medicine
6. Glucagon-Like Peptide 1 Receptor Agonists and Chronic Lower Respiratory Disease Exacerbations Among Patients With Type 2 Diabetes
   Yasser Albogami, Kenneth J. Cusi, Michael J. Daniels, Yu‐Jung Jenny Wei, Almut Gertrud Winterstein · 2021 · Diabetes Care
7. How did the COVID-19 crisis affect different types of workers in the developing world?
   Maurice D. Kugler, Mariana Viollaz, Daniel Duque, Isis Gaddis, David Newhouse, Amparo Palacios-López, Michael Weber · 2023 · World Development
8. High-dimensional versus conventional propensity scores in a comparative effectiveness study of coxibs and reduced upper gastrointestinal complications
   Edeltraut Garbe, Sebastian Kloss, Marc Suling, Iris Pigeot, Sebastian Schneeweiß · 2012 · European Journal of Clinical Pharmacology
9. Clopidogrel and proton pump inhibitors - where do we stand in 2012?
   Michael Drepper · 2012 · World Journal of Gastroenterology
10. Observational studies of the association between glucose-lowering medications and cardiovascular outcomes: addressing methodological limitations
    Elisabetta Patorno, Amanda R. Patrick, Elizabeth M. Garry, Sebastian Schneeweiß, Victoria G. Gillet, Dorothee B. Bartels, Elvira L Massó-González, John D. Seeger · 2014 · Diabetologia
11. Studies with Many Covariates and Few Outcomes
    Elisabetta Patorno, Robert J. Glynn, Sonia Hernández–Dı́az, Jun Liu, Sebastian Schneeweiß · 2014 · Epidemiology
12. The importance and implications of comparator selection in pharmacoepidemiologic research
    Monica E D’Arcy, Til Stürmer‎, Jennifer Leigh Lund · 2018 · Current Epidemiology Reports
13. Use of low‐dose quetiapine increases the risk of major adverse cardiovascular events: results from a nationwide active comparator‐controlled cohort study
    Mikkel Højlund, Kjeld Andersen, Martin T. Ernst, Christoph Ulrich Correll, Jesper Hallas · 2022 · World Psychiatry
14. A Comparative Assessment of Observational Medical Outcomes Partnership and Mini-Sentinel Common Data Models and Analytics: Implications for Active Drug Safety Surveillance
    Yihua Xu, Xiaofeng Zhou, Brandon T. Suehs, Abraham G. Hartzema, Michael G. Kahn, Yola Moride, Brian C. Sauer, Qing Liu, Keran Moll, Margaret K. Pasquale et al. · 2015 · Drug Safety
15. Risks of peri‐ and postoperative complications with glucagon‐like peptide‐1 receptor agonists
    Klonoff, David C., Kim, Sun H., Galindo, Rodolfo J., Joseph, Jeffery I., Garrett, Valerie, Gombar, Saurabh, Aaron, Rachel E., Tian, Tiffany, Kerr, David · 2024 · Diabetes, Obesity and Metabolism
16. Evaluation of risk mitigation measures for people with substance use disorders to address the dual public health crises of COVID-19 and overdose in British Columbia: a mixed-method study protocol
    B. Nosyk, A. Slaunwhite, K. Urbanoski, N. Hongdilokkul, Heather Palis, Kurt Lock, J. Min, Bin Zhao, K. Card, Brittany Barker et al. · 2020 · BMJ Open
17. Observing versus Predicting: Initial Patterns of Filling Predict Long‐Term Adherence More Accurately Than High‐Dimensional Modeling Techniques
    Jessica Myers Franklin, William H. Shrank, Joyce Lii, Alexis A. Krumme, Olga S. Matlin, Troyen A. Brennan, Niteesh K. Choudhry · 2015 · Health Services Research
18. Comparison of the Risks of Opioid Abuse or Dependence Between Tapentadol and Oxycodone: Results From a Cohort Study
    Maria Soledad Cepeda, Daniel Fife, Qianli Ma, Patrick B. Ryan · 2013 · Journal of Pain
19. Variable Selection in Causal Inference using a Simultaneous Penalization Method
    Ashkan Ertefaie, Masoud Asgharian, David A. Stephens · 2017 · Journal of Causal Inference
20. Comparative effectiveness of dabigatran and rivaroxaban versus warfarin for the treatment of non-valvular atrial fibrillation
    Lindsay G.S. Bengtson, Pamela L. Lutsey, Lin Y. Chen, Richard F. MacLehose, Álvaro Alonso · 2016 · Journal of Cardiology
21. Organized structure of real-world evidence best practices: moving from fragmented recommendations to comprehensive guidance
    Ashley A. Jaksa, James J. Wu, Pall F. Jonsson, Hans‐Georg Eichler, Sarah E. Vititoe, Nicolle M. Gatto · 2021 · Journal of Comparative Effectiveness Research
22. Propensity score methodology for confounding control in health care utilization databases
    Elisabetta Patorno, Alessandra Grotta, Rino Bellocco, Sebastian Schneeweiß · 2022 · Epidemiology Biostatistics and Public Health
23. Proton pump inhibitors and risk of colorectal cancer
    Devin Abrahami, Emily Gibson McDonald, Mireille E. Schnitzer, Alan N. Barkun, Samy Suissa, Laurent Azoulay · 2021 · Gut
24. How Confident Are We About Observational Findings in Health Care: A Benchmark Study
    Martijn J. Schuemie, M. Soledad Cepede, Marc A. Suchard, Jianxiao Yang, Yuxi Tian Alejandro Schuler, Patrick B. Ryan, David Madigan, George M. Hripcsak · 2020 · Harvard Data Science Review
25. Risk of amputations associated with SGLT2 inhibitors compared to DPP‐4 inhibitors: A propensity‐matched cohort study
    Sruthi Adimadhyam, Todd A. Lee, Gregory Sampang Calip, Daphne E. Smith Marsh, Brian Thomas Layden, Glen T. Schumock · 2018 · Diabetes Obesity and Metabolism
26. Signal Detection and Monitoring Based on Longitudinal Healthcare Data
    Marc Suling, Iris Pigeot · 2012 · Pharmaceutics
27. Long-term Outcomes Associated With Implantable Cardioverter Defibrillator in Adults With Chronic Kidney Disease
    Nisha Bansal, Adam A. Szpiro, Kristi Reynolds, David H. Smith, David J. Magid, Jerry H. Gurwitz, Frederick A. Masoudi, Robert T. Greenlee, Grace H. Tabada, Sue Hee Sung et al. · 2018 · JAMA Internal Medicine
28. Comparative Effectiveness and Safety of Direct Oral Anticoagulants and Warfarin in Patients With Atrial Fibrillation and Chronic Liver Disease: A Nationwide Cohort Study
    Oluwadolapo D. Lawal, Herbert D. Aronow, Fisayomi O. Shobayo, Anne Lamont Hume, Tracey H. Taveira, Kelly L. Matson, Yichi Zhang, Xuerong Wen · 2023 · Circulation
29. Making fair comparisons in pregnancy medication safety studies: An overview of advanced methods for confounding control
    Mollie E. Wood, Kate L. Lapane, Marleen M. H. J. van Gelder, Dheeraj Rai, Hedvig Nordeng · 2017 · Pharmacoepidemiology and Drug Safety
30. Real-Life Benefits of Statins for Cardiovascular Prevention in Elderly Subjects: A Population-Based Cohort Study
    Julien Bezin, Nicholas D Moore, Yohann Mansiaux, Philippe Gabríel Steg, Antoine Pariente · 2019 · The American Journal of Medicine
31. Antiepileptic drugs and the risk of ischaemic stroke and myocardial infarction: a population-based cohort study
    Christel Renoux, Sophie Dell’Aniello, Olli Saarela, Kristian B. Filion, Jean‐François Boivin · 2015 · BMJ Open
32. Applications of propensity score methods in observational comparative effectiveness and safety research: where have we come and where should we go?
    Bijan J. Borah, James P. Moriarty, William H. Crown, Jalpa A. Doshi · 2013 · Journal of Comparative Effectiveness Research
33. Long-Acting Bronchodilator Initiation in COPD and the Risk of Adverse Cardiopulmonary Events
    Samy Suissa, Sophie Dell’Aniello, Pierre Ernst · 2016 · CHEST Journal
34. Sulfonylureas as Initial Treatment for Type 2 Diabetes and the Risk of Severe Hypoglycemia
    Oriana Hoi Yun Yu, Laurent Azoulay, Hui Yin, Kristian B. Filion, Samy Suissa · 2017 · The American Journal of Medicine
35. On Measurement Bias in Causal Inference
    Judea Pearl · 2012 · arXiv (Cornell University)
36. Examining the risk of depression or self-harm associated with incretin-based therapies used to manage hyperglycaemia in patients with type 2 diabetes: a cohort study using the UK Clinical Practice Research Datalink
    Gamble, John-Michael, Chibrikov, Eugene, Midodzi, William K, Twells, Laurie K, Majumdar, Sumit R · 2018 · BMJ Open
37. Targeted learning in real‐world comparative effectiveness research with time‐varying interventions
    Romain S. Neugebauer, Julie A. Schmittdiel, Mark J. van der Laan · 2014 · Statistics in Medicine
38. Generalization Bounds and Representation Learning for Estimation of Potential Outcomes and Causal Effects
    Fredrik Johansson, Uri Shalit, Nathan Kallus, David Alexander Sontag · 2020 · arXiv (Cornell University)
39. Mortality Among Mothers Whose Children Were Taken Into Care by Child Protection Services: A Discordant Sibling Analysis
    Elizabeth Wall‐Wieler, Leslie Leon Roos, Nathan Christopher Nickel, Dan G. Chateau, Marni D Brownell · 2018 · American Journal of Epidemiology
40. Observational evidence and strength of evidence domains: case examples
    Maya Elin O'Neil, Nancy D Berkman, Lisa Hartling, Stephanie Chang, Johanna Anderson, Makalapua L. Motu’apuaka, Jeanne‐Marie Guise, Marian S. McDonagh · 2014 · Systematic Reviews
41. Health outcomes of young children born to mothers who received 2009 pandemic H1N1 influenza vaccination during pregnancy: retrospective cohort study
    Laura K. Walsh, Jessy Donelle, Linda A. Dodds, Steven Hawken, Kumanan R Wilson, Eric Ian Benchimol, Pranesh K. Chakraborty, Astrid Guttmann, Jeffrey C. Kwong, Noni E. MacDonald et al. · 2019 · BMJ
42. Design considerations in an active medical product safety monitoring system.
    Gagne, Joshua J., Fireman, Bruce, Ryan, Patrick B., Maclure, Malcolm, Gerhard, Tobias, Toh, Sengwee, Rassen, Jeremy A., Nelson, Jennifer C., Schneeweiss, Sebastian · 2012 · Pharmacoepidemiology and Drug Safety
43. Assessment of stimulant use and cardiovascular event risks among older adults
    Tadrous, Mina, Shakeri, Ahmad, Chu, Cherry, Watt, Jennifer, Mamdani, Muhammad M., Juurlink, David N., Gomes, Tara · 2021 · JAMA Network Open
44. Bringing cohort studies to the bedside: framework for a ‘green button’ to support clinical decision-making
    Blanca Gallego, Scott R. Walter, Richard Osborne Day, Adam G. Dunn, Vijay Sivaraman, Nigam Haresh Shah, Chris Longhurst, Enrico W Coiera · 2015 · Journal of Comparative Effectiveness Research
45. Risks of venous thromboembolism in patients with liver cirrhosis: a nationwide cohort study in Taiwan
    K.‐J. Ng, Young‐Kyun Lee, Ming‐Yi Huang, Chao‐Yu Hsu, Yu‐Chieh Su · 2014 · Journal of Thrombosis and Haemostasis
46. Multivariate-adjusted pharmacoepidemiologic analyses of confidential information pooled from multiple health care utilization databases
    Jeremy A. Rassen, Jerry Avorn, Sebastian Schneeweiß · 2010 · Pharmacoepidemiology and Drug Safety
47. Incidence of Hospitalized Rhabdomyolysis with Statin and Fibrate Use in an Insured US Population
    Kandace L. Amend, Joan E. Landon, Veena Hoffman, Steve J. Niemcryk, Andrew T. McAfee · 2011 · Annals of Pharmacotherapy
48. Propensity score prediction for electronic healthcare databases using super learner and high-dimensional propensity score methods
    Cheng Ju, Mary Combs, Samuel Lendle, Jessica Myers Franklin, Richard Wyss, Sebastian Schneeweiß, Mark J. van der Laan · 2019 · Journal of Applied Statistics
49. Prenatal Opioid Analgesics and the Risk of Adverse Birth Outcomes
    Susan B. Brogly, Maria P. Vélez, Martha M. Werler, Wenbin Li, Andi Camden, Astrid Guttmann · 2021 · Epidemiology
50. Precision medicine and the cursed dimensions
    Dennis L. Barbour · 2019 · npj Digital Medicine
51. A method for controlling complex confounding effects in the detection of adverse drug reactions using electronic health records
    Ying Li, Hojjat Salmasian, Santiago Vilar, Herbert S Chase, Carol Friedman, Ying Wei · 2013 · Journal of the American Medical Informatics Association
52. Performance of the high-dimensional propensity score in adjusting for unmeasured confounders
    Jason R. Guertin, Elham Rahme, Jacques LeLorier · 2016 · European Journal of Clinical Pharmacology
53. Association of first trimester prescription opioid use with congenital malformations in the offspring: population based cohort study
    Brian T. Bateman, Sonia Hernández–Dı́az, Loreen Straub, Yanmin Zhu, Kathryn J. Gray, Rishi J. Desai, Helen Mogun, Nileesa Gautam, Krista F. Huybrechts · 2021 · BMJ
54. Comparative Effectiveness of Sodium-Glucose Cotransporter 2 Inhibitors vs Sulfonylureas in Patients With Type 2 Diabetes
    Yan Xie, Benjamin C. Bowe, Andrew K. Gibson, Janet B. McGill, Geetha S. Maddukuri, Ziyad Al‐Aly · 2021 · JAMA Internal Medicine
55. Risk of hospitalised bleeding in comparisons of oral anticoagulant options for the primary treatment of venous thromboembolism
    Lutsey, Pamela L., Zakai, Neil A., MacLehose, Richard F., Norby, Faye L., Walker, Rob F., Roetker, Nicholas S., Adam, Terrence J., Alonso, Alvaro · 2019 · British Journal of Haematology
56. Adjusting for indirectly measured confounding using large-scale propensity score
    Linying Zhang, Zhaoran Wang, Martijn J. Schuemie, David M. Blei, George M. Hripcsak · 2022 · Journal of Biomedical Informatics
57. Active Safety Monitoring of Newly Marketed Medications in a Distributed Data Network: Application of a Semi-Automated Monitoring System
    J J Gagne, Robert J. Glynn, Jeremy A. Rassen, Alexander Muir Walker, Gregory W. Daniel, G Sridhar, Sebastian Schneeweiß · 2012 · Clinical Pharmacology & Therapeutics
58. Head to head comparison of the propensity score and the high-dimensional propensity score matching methods
    Jason R. Guertin, Elham Rahme, Colin R. Dormuth, Jacques LeLorier · 2016 · BMC Medical Research Methodology
59. Rising Vancomycin-Resistant Enterococcus Infections in Hospitalized Children in the United States
    Daniel J. Adams, Matthew D. Eberly, Anthony Goudie, Cade M. Nylund · 2016 · Hospital Pediatrics
60. Association between perioperative beta blocker use and cancer survival following surgical resection
    Reilly Musselman, Sean Bennett, Wenbin Li, Muhammad Mamdani, Tara Gomes, Carl van Walraven, Robin P. Boushey, Omar Abdullah Al-Obeed, Mohammed A. Al-Omran, Rebecca C. Auer · 2018 · European Journal of Surgical Oncology
61. Data Mining for Adverse Drug Events With a Propensity Score-matched Tree-based Scan Statistic
    Shirley V. Wang, Judith C. Maro, Elande Baro, Rima Izem, Inna Dashevsky, James R. Rogers, Michael Nguyen, Joshua J. Gagne, Elisabetta Patorno, Krista F. Huybrechts et al. · 2018 · Epidemiology
62. Sulfonylureas as initial treatment for type 2 diabetes and the risk of adverse cardiovascular events: A population‐based cohort study
    Kristian B. Filion, Antonios Douros, Laurent Azoulay, Hui Yin, Oriana Hoi Yun Yu, Samy Suissa · 2019 · British Journal of Clinical Pharmacology
63. Accounting for uncertainty in confounder and effect modifier selection when estimating average causal effects in generalized linear models
    Chi Wang, Francesca Dominici, Giovanni Parmigiani, Corwin Matthew Zigler · 2015 · Biometrics
64. Improving Automated Database Studies
    Wayne A. Ray · 2011 · Epidemiology
65. Goals in Nutrition Science 2015–2020
    Allison, David B., Bassaganya-Riera, Josep, Burlingame, Barbara, Brown, Andrew W., le Coutre, Johannes, Dickson, Suzanne L., van Eden, Willem, Garssen, Johan, Hontecillas, Raquel, Khoo, Chor San H. et al. · 2015 · Frontiers in Nutrition
66. Estimating Causal Effects in Observational Studies Using Electronic Health Data: Challenges and (some) Solutions
    Elizabeth A. Stuart, Eva H. DuGoff, Michael T. Abrams, David S. Salkever, Donald M. Steinwachs · 2013 · eGEMs (Generating Evidence & Methods to improve patient outcomes)
67. Maternal Mental Health after Custody Loss and Death of a Child: A Retrospective Cohort Study Using Linkable Administrative Data
    Elizabeth Wall‐Wieler, Leslie Leon Roos, James M. Bolton, Marni D Brownell, Nathan Christopher Nickel, Dan G. Chateau · 2017 · The Canadian Journal of Psychiatry
68. Evaluating sources of bias in observational studies of angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker use during COVID-19: beyond confounding
    Jordana B. Cohen, Lucy D’Agostino McGowan, Elizabeth T. Jensen, Joseph Rigdon, Andrew Michael South · 2020 · Journal of Hypertension
69. Assessing the impact of unmeasured confounders for credible and reliable real‐world evidence
    Xiang Zhang, James D. Stamey, Maya B. Mathur · 2020 · Pharmacoepidemiology and Drug Safety
70. High‐dimensional propensity scores for empirical covariate selection in secondary database studies: Planning, implementation, and reporting
    Jeremy A. Rassen, Patrick Blin, Sebastian Kloss, Romain S. Neugebauer, Robert William Platt, Anton Pottegård, Sebastian Schneeweiß, Sengwee Toh · 2022 · Pharmacoepidemiology and Drug Safety
71. Nirmatrelvir-Ritonavir and COVID-19 Mortality and Hospitalization Among Patients With Vulnerability to COVID-19 Complications
    Colin R. Dormuth, Jason D. Kim, Anat Fisher, Jolanta Piszczek, I fan Kuo · 2023 · JAMA Network Open
72. High‐dimensional propensity score algorithm in comparative effectiveness research with time‐varying interventions
    Romain S. Neugebauer, Julie A. Schmittdiel, Zheng Zhu, Jeremy A. Rassen, John D. Seeger, Sebastian Schneeweiß · 2014 · Statistics in Medicine
73. Outcomes Associated With Early Preventive Dental Care Among Medicaid-Enrolled Children in Alabama
    Justin L. Blackburn, Michael A. Morrisey, Bisakha Sen · 2017 · Archives of Pediatrics and Adolescent Medicine
74. Comparative effectiveness of radical prostatectomy with adjuvant radiotherapy versus radiotherapy plus androgen deprivation therapy for men with advanced prostate cancer
    Thomas L. Jang, Neal Patel, Izak Faiena, Kushan Dilip Radadia, Dirk F. Moore, Sammy E. Elsamra, Eric A. Singer, Mark N. Stein, James Andrew Eastham, Peter T. Scardino et al. · 2018 · Cancer
75. Comparative effectiveness of branded vs. generic versions of antihypertensive, lipid-lowering and hypoglycemic substances: a population-wide cohort study
    Yuxi Tian, Berthold Reichardt, Daniela Dunkler, Milan Hronský, Wolfgang C. Winkelmayer­, Anna Bucsics, Susanne Strohmaier, Georg Heinze · 2020 · Scientific Reports
76. The European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP)
    Canary Wharf, E London · 2012
77. Sources of Hospital Variation in Short-Term Readmission Rates After Percutaneous Coronary Intervention
    Robert W. Yeh, Kenneth Rosenfield, Katya Zelevinsky, Laura Mauri, Rahul Sakhuja, Daniel M. Shivapour, Ann F. Lovett, Bonnie H. Weiner, Alice K. Jacobs, Sharon‐Lise T. Normand · 2012 · Circulation Cardiovascular Interventions
78. Effects of expanding the look‐back period to all available data in the assessment of covariates
    Sonja S. Nakasian, Jeremy A. Rassen, Jessica Myers Franklin · 2017 · Pharmacoepidemiology and Drug Safety
79. Tramadol for noncancer pain and the risk of hyponatremia
    Fournier, Jean-Pascal, Yin, Hui, Nessim, Sharon J., Montastruc, Jean-Louis, Azoulay, Laurent · 2015 · The American Journal of Medicine
80. Collaborative-controlled LASSO for constructing propensity score-based estimators in high-dimensional data
    Cheng Ju, Richard Wyss, Jessica Myers Franklin, Sebastian Schneeweiß, Jenny Häggström, Mark J. van der Laan · 2017 · Statistical Methods in Medical Research
81. Clinical Outcomes of Direct Oral Anticoagulants vs Warfarin for Extended Treatment of Venous Thromboembolism
    Margaret C. Fang, Kristi Reynolds, Dongjie Fan, Priya A. Prasad, Sue Hee Sung, Cecilia Portugal, Elisha A. Garcia, Alan S. Go · 2023 · JAMA Network Open
82. Antipsychotic Drug Use and the Risk of Venous Thromboembolism in Elderly Patients With Dementia
    Niklas Schmedt, Edeltraut Garbe · 2013 · Journal of Clinical Psychopharmacology
83. Metformin and low levels of thyroid-stimulating hormone in patients with type 2 diabetes mellitus
    Jean‐Pascal Fournier, Hui Yin, Oriana Hoi Yun Yu, Laurent Azoulay · 2014 · Canadian Medical Association Journal
84. Scalable collaborative targeted learning for high-dimensional data
    Cheng Ju, Susan Gruber, Samuel Lendle, Antoine Chambaz, Jessica Myers Franklin, Richard Wyss, Sebastian Schneeweiß, Mark J. van der Laan · 2017 · Statistical Methods in Medical Research
85. Comparative risk of harm associated with trazodone or atypical antipsychotic use in older adults with dementia: a retrospective cohort study
    Jennifer Ann Watt, Tara Gomes, Susan E. Bronskill, Anjie Huang, Peter C. Austin, Joanne M.-W. Ho, Sharon Elizabeth Straus · 2018 · Canadian Medical Association Journal
86. Comparative Effectiveness of the Sodium–Glucose Cotransporter 2 Inhibitor Empagliflozin Versus Other Antihyperglycemics on Risk of Major Adverse Kidney Events
    Yan Xie, Benjamin C. Bowe, Andrew K. Gibson, Janet B. McGill, Yan Yan, Geetha S. Maddukuri, Ziyad Al‐Aly · 2020 · Diabetes Care
87. Impact of immortal person-time and time scale in comparative effectiveness research for medical devices: a case for implantable cardioverter-defibrillators
    Xiaojuan Mi, Bradley G. Hammill, Lesley H. Curtis, Melissa A. Greiner, Soko Setoguchi · 2013 · Journal of Clinical Epidemiology
88. Zoo or Savannah? Choice of Training Ground for Evidence-Based Pharmacovigilance
    Norén, G. Niklas, Caster, Ola, Juhlin, Kristina, Lindquist, Marie · 2014 · Drug Safety
89. Proton pump inhibitors, genetic polymorphisms and response to clopidogrel therapy
    Himawan Fernando, Anthony Michael Dart, Karlheinz Peter, James A. Shaw · 2011 · Thrombosis and Haemostasis
90. Comparative Effectiveness of Preventative Therapy for Venous Thromboembolism After Coronary Artery Bypass Graft Surgery
    Alexander Kulik, Jeremy A. Rassen, Jessica A. Myers, Sebastian Schneeweiß, Joshua J. Gagne, Jennifer M. Polinski, Jun Liu, Michael A. Fischer, Niteesh K. Choudhry · 2012 · Circulation Cardiovascular Interventions
91. Real‐World Evidence: What It Is and What It Can Tell Us According to the International Society for Pharmacoepidemiology (ISPE) Comparative Effectiveness Research (CER) Special Interest Group (SIG)
    Hongbo Yuan, Mohammed Sanni Ali, Emily Brouwer, Cynthia J. Girman, Jeff Jianfei Guo, Jennifer Leigh Lund, Elisabetta Patorno, Jonathan L. Slaughter, Xuerong Wen, Dimitri Bennett · 2018 · Clinical Pharmacology & Therapeutics
92. Kidney, Cardiac, and Safety Outcomes Associated With α-Blockers in Patients With CKD: A Population-Based Cohort Study
    Gregory L. Hundemer, Greg A. Knoll, William Petrcich, Swapnil S. Hiremath, Marcel Ruzicka, Kevin D. Burns, Cedric Edwards, Ann L. Bugeja, Emily Rhodes, Manish M. Sood · 2020 · American Journal of Kidney Diseases
93. Using temporal patterns in medical records to discern adverse drug events from indications.
    Yi Liu, Paea LePendu, Srinivasan V. Iyer, Nigam Haresh Shah · 2012 · Europe PMC (PubMed Central)
94. Guidance for design and analysis of observational studies of fetal and newborn outcomes following COVID-19 vaccination during pregnancy
    Deshayne B. Fell, Michelle C. Dimitris, Jennifer A. Hutcheon, Justin R. Ortiz, Robert William Platt, Annette K. Regan, David A. Savitz · 2021 · Vaccine
95. Cardiovascular risks associated with low-dose ibuprofen and diclofenac as used OTC
    Nicholas D Moore, Francesco Salvo, Mai Duong, Patrick Blin, Antoine Pariente · 2013 · Expert Opinion on Drug Safety
96. Opioid epidemic: lessons learned and updated recommendations for misuse involving prescription versus non-prescription opioids
    Ajda Bedene, Albert Dahan, Frits Richard Rosendaal, Eveline L.A. van Dorp · 2022 · Expert Review of Clinical Pharmacology
97. 5α-Reductase Inhibitors and the Risk of Cancer-Related Mortality in Men With Prostate Cancer
    Laurent Azoulay, María Eberg, Serge Benayoun, Michaël Pollak · 2015 · JAMA Oncology
98. Are the Safety Profiles of Antipsychotic Drugs Used in Dementia the Same? An Updated Review of Observational Studies
    Gianluca Trifirò, Janet Sultana, Edoardo Spina · 2014 · Drug Safety
99. Use of biologics during pregnancy and risk of serious infections in the mother and baby: a Canadian population-based cohort study
    Nicole Tsao, Larry David Lynd, Eric C. Sayre, Mohsen Sadatsafavi, Gillian E. Hanley, Mary A. De Vera · 2019 · BMJ Open
100. Perinatal selective serotonin reuptake inhibitor (SSRI) and other antidepressant exposure effects on anxiety and depressive behaviors in offspring: A review of findings in humans and rodent models
     Sarah Michelle Hutchison, Louise C. Mâsse, Jodi L. Pawluski, Tim F. Oberlander · 2020 · Reproductive Toxicology